A Randomized, Open-label, Crossover Phase 1 Study to Evaluate the Bioequivalence Following a Single Oral Dose Administration of SYR-472 25mg and 50mg Tablets in Healthy Adult Male Subjects

Name: A Randomized, Open-label, Crossover Phase 1 Study to Evaluate the Bioequivalence Following a Single Oral Dose Administration of SYR-472 25mg and 50mg Tablets in Healthy Adult Male Subjects
Creator: Vivli
Published: 2026-04-15 18:14:09
License: 暂无描述

DataCite Commons2026-04-15 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012997/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to investigate the bioequivalence of 2 tablets of SYR-472 25 milligram (mg) and 1 tablet of SYR-472 50 mg administered to healthy adult males.

提供机构：

Vivli

创建时间：

2026-04-15